Articles

Export this record

Export selected records

Export record to excel

File type to download

Beta version

Record title

Bendamustine combined with rituximab for patients with relapsed or refractory diffuse large B cell lymphoma

Record identifier

TN_cdi_proquest_journals_1496032113

Bendamustine combined with rituximab for patients with relapsed or refractory diffuse large B cell lymphoma

ACCESS
https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1496032113

Bendamustine combined with rituximab for patients with relapsed or refractory diffuse large B cell lymphoma

Full title

Bendamustine combined with rituximab for patients with relapsed or refractory diffuse large B cell lymphoma

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

Journal title

Annals of hematology, 2014, Vol.93 (3), p.403-409

Record Identifier

TN_cdi_proquest_journals_1496032113

Language

English

Formats

Publication information

Publisher

Subjects

Subjects and topics

Adult Aged Aged, 80 and over Aggressive lymphoma Alkylating agents Analysis Anemia Antibodies, Monoclonal, Murine-Derived - administration & dosage Antibodies, Monoclonal, Murine-Derived - adverse effects Antibodies, Monoclonal, Murine-Derived - therapeutic use Antimitotic agents Antineoplastic agents Antineoplastic Agents - administration & dosage Antineoplastic Agents - adverse effects Antineoplastic Agents - therapeutic use Antineoplastic Agents, Alkylating - administration & dosage Antineoplastic Agents, Alkylating - adverse effects Antineoplastic Agents, Alkylating - therapeutic use Antineoplastic Combined Chemotherapy Protocols - administration & dosage Antineoplastic Combined Chemotherapy Protocols - adverse effects Antineoplastic Combined Chemotherapy Protocols - therapeutic use Bendamustine Bendamustine Hydrochloride Cancer Care and treatment CD20 Chemotherapy Chemotherapy-Induced Febrile Neutropenia - epidemiology Diffuse large B cell lymphoma Dose-Response Relationship, Drug Drug Resistance, Neoplasm Female Follow-Up Studies Hematology Humans Incidence Intention to Treat Analysis Leukemia Lymphoma, Large B-Cell, Diffuse - drug therapy Lymphoma, Large B-Cell, Diffuse - pathology Lymphoma, Large B-Cell, Diffuse - prevention & control Lymphomas Male Medicine Medicine & Public Health Middle Aged Neoplasm Staging Nitrogen Mustard Compounds - administration & dosage Nitrogen Mustard Compounds - adverse effects Nitrogen Mustard Compounds - therapeutic use Oncology Original Original Article Patient Dropouts Rituximab Secondary Prevention Survival Analysis United States - epidemiology

More information

SCOPE AND CONTENTS

Contents

ALTERNATIVE TITLES

Full title

Identifiers

PRIMARY IDENTIFIERS

Record Identifier

TN_cdi_proquest_journals_1496032113

Permalink

https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1496032113

OTHER IDENTIFIERS

ISSN

E-ISSN

DOI

How to access this item

Online

1 item

How to access?

Login with a Library card